Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- National Jewish Health
- Study ID
- NCT06270576
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Asthma
- Asthma; Eosinophilic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Lipopolysaccharides — DRUGLPS aka endotoxin is a component of bacterial cell walls and is ubiquitous in the environment. It is found in pet dander, house dust and environmental dusts and has been heavily studied in asthma.
Study Details
A phase I clinical research study aimed at determining mechanisms that regulate airway mucosal inflammation in asthma endotypes using intranasal administration of endotoxin (lipopolysaccharide from E. coli) in healthy controls and subjects diagnosed with asthma.
Key Dates
- Start date
- Apr 30, 2024
- Status verified
- Feb 2024
- Primary completion
- Apr 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Asthma GroupSubjects diagnosed with one of the three asthma endotypes being studied (T2, T1, or T17).
- Active Comparator: Control GroupSubjects with no diagnosis of asthma or other respiratory disease and are deemed healthy.
Primary Outcome Measure
Neutrophil heterogeneity using single cell RNA sequencing [ Time Frame: We anticipate that the study will run over 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Jewish Health | Denver | Colorado | 80206 | William J Janssen, MD 303-398-1366 Olivia M VerBurg, BA 303-398-1201 William J Janssen, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Denver, CO
By condition
By specialty
By research site
Related Studies
- Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyPHASE2 · Recruiting · National Jewish Health · Denver, Colorado
- Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsRecruiting · University of Colorado, Denver · Aurora, Colorado
- Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in AsthmaPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Study to Improve Deployment Related Asthma by Using L-Citrulline SupplementationPHASE2 · Recruiting · University of Colorado, Denver · Denver, Colorado